Top

Gepubliceerd in:

28-02-2023 | Original Article

Predictors of Full Recovery in Individuals with Emotional Disorders: One-Year Follow-Up Secondary Analysis of the PsicAP Randomized Controlled Trial

Auteurs: César González-Blanch, Leonardo Adrián Medrano, Paloma Ruíz-Rodríguez, Roger Muñoz-Navarro, Juan A. Moriana, Antonio Cano-Vindel

Gepubliceerd in: Cognitive Therapy and Research | Uitgave 3/2023

Abstract

Background

This study examines potential predictors of full recovery in emotional disorders —considering symptom plus functional outcomes at one-year follow-up—in a sample derived from a randomized controlled trial aimed to test the efficacy of adding transdiagnostic group cognitive-behavioural therapy (TD-GCBT) to treatment-as-usual (TAU) in primary care.

Methods

A total of 387 individuals were examined, 128 (33.1%) achieved a full recovery at one-year follow-up. Baseline data on sociodemographic, treatment, disability, clinical, and cognitive variables were analysed using independent groups comparisons and hierarchical binary logistic regression. The groups were compared in terms of health-related quality of life (HRQoL).

Results

Four variables emerged as significant predictors of full recovery at one-year: allocation to the TD-GCBT group, no antidepressant use, higher levels of cognitive reappraisal, and fewer somatic symptoms. Between-group comparison showed that the full-recovery group had notably higher levels of HRQoL at one-year follow-up assessment (Cohen’s d = 0.77).

Conclusion

The addition of TD-GCBT to TAU was the main predictor for full recovery. After controlling for depressive symptoms, individuals who were not taking antidepressants at baseline were twice as likely to achieve full recovery compared to those taking antidepressants. These findings may have implications for the standard treatment approach for emotional disorders in primary care.

vorige artikel Longitudinal Relations Between Emotion Regulation and Internalizing Symptoms in Emerging Adults During the Covid-19 Pandemic

volgende artikel Beyond Positive Affect: Discrete Positive Emotions Differentiate Major Depression from Social Anxiety Disorder

Alleen toegankelijk voor geautoriseerde gebruikers

Aldao, A., Nolen-Hoeksema, S., & Schweizer, S. (2010). Emotion-regulation strategies across psychopathology: a meta-analytic review. Clinical Psychology Review, 30(2), 217–237. https://doi.org/10.1016/j.cpr.2009.11.004.CrossRefPubMed

Amati, F., Banks, C., Greenfield, G., & Green, J. (2018). Predictors of outcomes for patients with common mental health disorders receiving psychological therapies in community settings: a systematic review. Journal of Public Health, 40(3), e375–e387. https://doi.org/10.1093/pubmed/fdx168.CrossRefPubMed

Berking, M., Wirtz, C. M., Svaldi, J., & Hofmann, S. G. (2014). Emotion regulation predicts symptoms of depression over five years. Behaviour Research and Therapy, 57, 13–20. https://doi.org/10.1016/j.brat.2014.03.003.CrossRefPubMed

Berking, M., Wupperman, P., Reichardt, A., Pejic, T., Dippel, A., & Znoj, H. (2008). Emotion-regulation skills as a treatment target in psychotherapy. Behaviour Research and Therapy, 46(11), 1230–1237. https://doi.org/10.1016/j.brat.2008.08.005.CrossRefPubMed

Bortolotti, B., Menchetti, M., Bellini, F., Montaguti, M. B., & Berardi, D. (2008). Psychological interventions for major depression in primary care: a meta-analytic review of randomized controlled trials. General hospital psychiatry, 30(4), 293–302. https://doi.org/10.1016/j.genhosppsych.2008.04.001.CrossRefPubMed

Bridges, A. J., Gregus, S. J., Rodriguez, J. H., Andrews, A. R., Villalobos, B. T., Pastrana, F. A., & Cavell, T. A. (2015). Diagnoses, intervention strategies, and rates of functional improvement in integrated behavioral health care patients. Journal of Consulting and Clinical Psychology, 83(3), 590–601. https://doi.org/10.1037/a0038941.CrossRefPubMedPubMedCentral

Buist-Bouwman, M. A., De Graaf, R., Vollebergh, W. A., Alonso, J., Bruffaerts, R., Ormel, J., & Investigators, E. S. M. (2006). Functional disability of mental disorders and comparison with physical disorders: a study among the general population of six european countries. Acta Psychiatrica Scandinavica, 113(6), 492–500. https://doi.org/10.1111/j.1600-0447.2005.00684.x.CrossRefPubMed

Cano-Vindel, A., Munoz-Navarro, R., Moriana, J. A., Ruiz-Rodriguez, P., Medrano, L. A., & Gonzalez-Blanch, C. (2021). Transdiagnostic group cognitive behavioral therapy for emotional disorders in primary care: the results of the PsicAP randomized controlled trial. Psychological Medicine, 1–13. https://doi.org/10.1017/S0033291720005498.

Clark, D. M., Layard, R., Smithies, R., Richards, D. A., Suckling, R., & Wright, B. (2009). Improving access to psychological therapy: initial evaluation of two UK demonstration sites. Behaviour research and therapy, 47(11), 910–920. https://doi.org/10.1016/j.brat.2009.07.010.CrossRefPubMedPubMedCentral

Fava, G. A., Benasi, G., Lucente, M., Offidani, E., Cosci, F., & Guidi, J. (2018). Withdrawal symptoms after serotonin-noradrenaline reuptake inhibitor discontinuation: systematic review. Psychotherapy and Psychosomatics, 87(4), 195–203. https://doi.org/10.1159/000491524.CrossRefPubMed

Fournier, J. C., DeRubeis, R. J., Hollon, S. D., Dimidjian, S., Amsterdam, J. D., Shelton, R. C., & Fawcett, J. (2010). Antidepressant drug effects and depression severity: a patient-level meta-analysis. Journal Of The American Medical Association, 303(1), 47–53. https://doi.org/10.1001/jama.2009.1943.CrossRefPubMed

Garcia-Gordillo, M. A., Adsuar, J. C., & Olivares, P. R. (2016). Normative values of EQ-5D-5L: in a spanish representative population sample from Spanish Health Survey, 2011. Quality of Life Research, 25(5), 1313–1321. https://doi.org/10.1007/s11136-015-1164-7.CrossRefPubMed

Gillett, G., Tomlinson, A., Efthimiou, O., & Cipriani, A. (2020). Predicting treatment effects in unipolar depression: a meta-review. Pharmacology & Therapeutics, 212, 107557. https://doi.org/10.1016/j.pharmthera.2020.107557.CrossRef

González-Blanch, C., Muñoz-Navarro, R., Medrano, L. A., Moriana, J. A., Ruiz-Rodríguez, P., & Cano-Vindel, A. (2021). Moderators and predictors of treatment outcome in transdiagnostic group cognitive-behavioral therapy for primary care patients with emotional disorders. Depression and Anxiety. https://doi.org/10.1002/da.23164. Advance online publication.CrossRefPubMed

Gross, J. J., & John, O. P. (2003). Individual differences in two emotion regulation processes: implications for affect, relationships, and well-being. Journal of Personality and Social Psychology, 85(2), 348–362. https://doi.org/10.1037/0022-3514.85.2.348.CrossRefPubMed

Hamilton, K. E., & Dobson, K. S. (2002). Cognitive therapy of depression: pretreatment patient predictors of outcome. Clinical Psychology Review, 22(6), 875–893. https://doi.org/10.1016/s0272-7358(02)00106-x.CrossRefPubMed

Harvey, P. D. (2006). Defining and achieving recovery from bipolar disorder. Journal of Clinical Psychiatry 67 Suppl, 9, 14–18. discussion 36–42https://www.ncbi.nlm.nih.gov/pubmed/16965184.

Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., Parkin, D., Bonsel, G., & Badia, X. (2011). Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Quality of Life Research, 20(10), 1727–1736. https://doi.org/10.1007/s11136-011-9903-x.CrossRefPubMedPubMedCentral

Hoedeman, R., Blankenstein, A. H., Krol, B., Koopmans, P. C., & Groothoff, J. W. (2010). The contribution of high levels of somatic symptom severity to sickness absence duration, disability and discharge. Journal of Occupational Rehabilitation, 20(2), 264–273. https://doi.org/10.1007/s10926-010-9239-3.CrossRefPubMedPubMedCentral

Hofmann, S. G., Sawyer, A. T., Fang, A., & Asnaani, A. (2012). Emotion dysregulation model of mood and anxiety disorders. Depression and Anxiety, 29(5), 409–416. https://doi.org/10.1002/da.21888.CrossRefPubMed

Hopko, D. R., Stanley, M. A., Reas, D. L., Wetherell, J. L., Beck, J. G., Novy, D. M., & Averill, P. M. (2003). Assessing worry in older adults: confirmatory factor analysis of the Penn state worry questionnaire and psychometric properties of an abbreviated model. Psychological Assessment, 15(2), 173–183. https://doi.org/10.1037/1040-3590.15.2.173.CrossRefPubMed

Hovenkamp-Hermelink, J. H. M., Jeronimus, B. F., Myroniuk, S., Riese, H., & Schoevers, R. A. (2021). Predictors of persistence of anxiety disorders across the lifespan: a systematic review. Lancet Psychiatry, 8(5), 428–443. https://doi.org/10.1016/S2215-0366(20)30433-8.CrossRefPubMed

Jaaskelainen, E., Juola, P., Hirvonen, N., McGrath, J. J., Saha, S., Isohanni, M., Veijola, J., & Miettunen, J. (2013). A systematic review and meta-analysis of recovery in schizophrenia. Schizophrenia Bulletin, 39(6), 1296–1306. https://doi.org/10.1093/schbul/sbs130.CrossRefPubMed

Judd, L. L., Akiskal, H. S., Maser, J. D., Zeller, P. J., Endicott, J., Coryell, W., Paulus, M. P., Kunovac, J. L., Leon, A. C., Mueller, T. I., Rice, J. A., & Keller, M. B. (1998). Major depressive disorder: a prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse. Journal of Affective Disorders, 50(2–3), 97–108. https://doi.org/10.1016/s0165-0327(98)00138-4.CrossRefPubMed

Kennedy, N., Foy, K., Sherazi, R., McDonough, M., & McKeon, P. (2007). Long-term social functioning after depression treated by psychiatrists: a review. Bipolar Disorders, 9(1–2), 25–37. https://doi.org/10.1111/j.1399-5618.2007.00326.x.CrossRefPubMed

Knight, M. J., Air, T., & Baune, B. T. (2018). The role of cognitive impairment in psychosocial functioning in remitted depression. Journal of Affective Disorders, 235, 129–134. https://doi.org/10.1016/j.jad.2018.04.051.CrossRefPubMed

Kroenke, K., Spitzer, R. L., & Williams, J. B. (2001). The PHQ-9: validity of a brief depression severity measure. Journal of General Internal Medicine, 16(9), 606–613. https://doi.org/10.1046/j.1525-1497.2001.016009606.x.CrossRefPubMedPubMedCentral

Kroenke, K., Spitzer, R. L., & Williams, J. B. (2002). The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosomatic Medicine, 64(2), 258–266. https://doi.org/10.1097/00006842-200203000-00008.CrossRefPubMed

Kroenke, K., Spitzer, R. L., Williams, J. B., Linzer, M., Hahn, S. R., deGruy, F. V. 3rd, & Brody, D. (1994). Physical symptoms in primary care. Predictors of psychiatric disorders and functional impairment. Archives of Family Medicine, 3(9), 774–779. https://doi.org/10.1001/archfami.3.9.774.

Kroenke, K., Spitzer, R. L., Williams, J. B., & Löwe, B. (2010). The Patient Health Questionnaire somatic, anxiety, and depressive Symptom Scales: a systematic review. General hospital psychiatry, 32(4), 345–359. https://doi.org/10.1016/j.genhosppsych.2010.03.006.CrossRefPubMed

Lam, R. W., Filteau, M. J., & Milev, R. (2011). Clinical effectiveness: the importance of psychosocial functioning outcomes. Journal of Affective Disorders, 132 Suppl(1), S9–S13. https://doi.org/10.1016/j.jad.2011.03.046.CrossRef

Lowe, B., Spitzer, R. L., Williams, J. B., Mussell, M., Schellberg, D., & Kroenke, K. (2008). Depression, anxiety and somatization in primary care: syndrome overlap and functional impairment. General Hospital Psychiatry, 30(3), 191–199. https://doi.org/10.1016/j.genhosppsych.2008.01.001.CrossRefPubMed

McKnight, P. E., & Kashdan, T. B. (2009). The importance of functional impairment to mental health outcomes: a case for reassessing our goals in depression treatment research. Clinical Psychology Review, 29(3), 243–259. https://doi.org/10.1016/j.cpr.2009.01.005.CrossRefPubMedPubMedCentral

Mercier, A., Auger-Aubin, I., Lebeau, J. P., Schuers, M., Boulet, P., Van Royen, P., & Peremans, L. (2014). Why do general practitioners prescribe antidepressants to their patients? A pilot study. Biopsychosocial Medicine, 8, 17. https://doi.org/10.1186/1751-0759-8-17.CrossRefPubMedPubMedCentral

Miller, I. W., Keitner, G. I., Schatzberg, A. F., Klein, D. N., Thase, M. E., Rush, A. J., Markowitz, J. C., Schlager, D. S., Kornstein, S. G., Davis, S. M., Harrison, W. M., & Keller, M. B. (1998). The treatment of chronic depression, part 3: psychosocial functioning before and after treatment with sertraline or imipramine. Journal of Clinical Psychiatry, 59(11), 608–619. https://doi.org/10.4088/jcp.v59n1108.CrossRefPubMed

Mintz, J., Mintz, L. I., Arruda, M. J., & Hwang, S. S. (1992). Treatments of depression and the functional capacity to work. Archives of General Psychiatry, 49(10), 761–768. https://doi.org/10.1001/archpsyc.1992.01820100005001.CrossRefPubMed

Mohiuddin, S., & Payne, K. (2014). Utility values for adults with Unipolar Depression: systematic review and Meta-analysis. Medical Decision Making, 34(5), 666–685. https://doi.org/10.1177/0272989X14524990.CrossRefPubMed

Munoz-Navarro, R., Cano-Vindel, A., Medrano, L. A., Schmitz, F., Ruiz-Rodriguez, P., Abellan-Maeso, C., Font-Payeras, M. A., & Hermosilla-Pasamar, A. M. (2017). Utility of the PHQ-9 to identify major depressive disorder in adult patients in spanish primary care centres. Bmc Psychiatry, 17(1), 291. https://doi.org/10.1186/s12888-017-1450-8.CrossRefPubMedPubMedCentral

Munoz-Navarro, R., Cano-Vindel, A., Moriana, J. A., Medrano, L. A., Ruiz-Rodriguez, P., Aguero-Gento, L., Rodriguez-Enriquez, M., Piza, M. R., & Ramirez-Manent, J. I. (2017). Screening for generalized anxiety disorder in spanish primary care centers with the GAD-7. Psychiatry Research, 256, 312–317. https://doi.org/10.1016/j.psychres.2017.06.023.CrossRefPubMed

Muñoz-Navarro, R., Adrián Medrano, L., González-Blanch, C., Carpallo-González, M., Olave, L., Iruarrizaga, I., Ruiz-Rodríguez, P., Moriana, J. A., & Cano-Vindel, A. (2021). Validity of brief scales for assessing transdiagnostic cognitive emotion regulation strategies in primary care patients with emotional disorders. European Journal of Psychological Assessment, 37(2), 86–94. https://doi.org/10.1027/1015-5759/a000584.CrossRef

Nolen-Hoeksema, S., & Morrow, J. (1991). A prospective study of depression and posttraumatic stress symptoms after a natural disaster: the 1989 Loma Prieta Earthquake. Journal of Personality and Social Psychology, 61(1), 115–121. https://doi.org/10.1037//0022-3514.61.1.115.CrossRefPubMed

OECD, & European Union (2018). Health at a Glance: Europe 2018. https://doi.org/10.1787/health_glance_eur-2018-en

Sheehan, D. V., Harnett-Sheehan, K., & Raj, B. A. (1996). The measurement of disability. International Clinical Psychopharmacology, 11 Suppl 3, 89–95. https://doi.org/10.1097/00004850-199606003-00015.CrossRefPubMed

Sheehan, D. V., Harnett-Sheehan, K., Spann, M. E., Thompson, H. F., & Prakash, A. (2011). Assessing remission in major depressive disorder and generalized anxiety disorder clinical trials with the discan metric of the Sheehan disability scale. International Clinical Psychopharmacology, 26(2), 75–83. https://doi.org/10.1097/YIC.0b013e328341bb5f.CrossRefPubMed

Sheehan, K. H., & Sheehan, D. V. (2008). Assessing treatment effects in clinical trials with the discan metric of the Sheehan disability scale. International Clinical Psychopharmacology, 23(2), 70–83. https://doi.org/10.1097/YIC.0b013e3282f2b4d6.CrossRefPubMed

Sleath, B., & Shih, Y. C. (2003). Sociological influences on antidepressant prescribing. Social Science and Medicine, 56(6), 1335–1344. https://doi.org/10.1016/s0277-9536(02)00132-6.CrossRefPubMed

Solvason, H. B., Ernst, H., & Roth, W. (2003). Predictors of response in anxiety disorders. Psychiatric Clinics of North America, 26(2), 411–433. https://doi.org/10.1016/s0193-953x(03)00027-3.CrossRefPubMed

Spitzer, R. L., Kroenke, K., & Williams, J. B. (1999). Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary care evaluation of Mental Disorders. Patient Health Questionnaire JAMA, 282(18), 1737–1744. https://doi.org/10.1001/jama.282.18.1737.CrossRefPubMed

Spitzer, R. L., Kroenke, K., Williams, J. B., & Lowe, B. (2006). A brief measure for assessing generalized anxiety disorder: the GAD-7. Archives of Internal Medicine, 166(10), 1092–1097. https://doi.org/10.1001/archinte.166.10.1092.CrossRefPubMed

van der Leeuw, G., Gerrits, M. J., Terluin, B., Numans, M. E., van der Feltz-Cornelis, C. M., van der Horst, H. E., Penninx, B. W., & van Marwijk, H. W. (2015). The association between somatization and disability in primary care patients. Journal of Psychosomatic Research, 79(2), 117–122. https://doi.org/10.1016/j.jpsychores.2015.03.001.CrossRefPubMed

Watkins, E. R. (2008). Constructive and unconstructive repetitive thought. Psychological Bulletin, 134(2), 163–206. https://doi.org/10.1037/0033-2909.134.2.163.CrossRefPubMedPubMedCentral

Wells, A., & Cartwright-Hatton, S. (2004). A short form of the metacognitions questionnaire: properties of the MCQ-30. Behaviour Research and Therapy, 42(4), 385–396. https://doi.org/10.1016/S0005-7967(03)00147-5.CrossRefPubMed

Whiston, A., Bockting, C. L. H., & Semkovska, M. (2019). Towards personalising treatment: a systematic review and meta-analysis of face-to-face efficacy moderators of cognitive-behavioral therapy and interpersonal psychotherapy for major depressive disorder. Psychological Medicine, 49(16), 2657–2668. https://doi.org/10.1017/S0033291719002812.CrossRefPubMed

Wirtz, C. M., Hofmann, S. G., Riper, H., & Berking, M. (2014). Emotion regulation predicts anxiety over a five-year interval: a cross-lagged panel analysis. Depression and Anxiety, 31(1), 87–95. https://doi.org/10.1002/da.22198.CrossRefPubMed

Wolitzky-Taylor, K. B., Arch, J. J., Rosenfield, D., & Craske, M. G. (2012). Moderators and non-specific predictors of treatment outcome for anxiety disorders: a comparison of cognitive behavioral therapy to acceptance and commitment therapy. Journal of Consulting and Clinical Psychology, 80(5), 786–799. https://doi.org/10.1037/a0029418.CrossRefPubMed

Zimmerman, M., McGlinchey, J. B., Posternak, M. A., Friedman, M., Attiullah, N., & Boerescu, D. (2006). How should remission from depression be defined? The depressed patient’s perspective. American Journal of Psychiatry, 163(1), 148–150. https://doi.org/10.1176/appi.ajp.163.1.148.CrossRefPubMed

Titel: Predictors of Full Recovery in Individuals with Emotional Disorders: One-Year Follow-Up Secondary Analysis of the PsicAP Randomized Controlled Trial
Auteurs: César González-Blanch
Leonardo Adrián Medrano
Paloma Ruíz-Rodríguez
Roger Muñoz-Navarro
Juan A. Moriana
Antonio Cano-Vindel
Publicatiedatum: 28-02-2023
Uitgeverij: Springer US
Gepubliceerd in: Cognitive Therapy and Research / Uitgave 3/2023
Print ISSN: 0147-5916
Elektronisch ISSN: 1573-2819
DOI: https://doi.org/10.1007/s10608-023-10360-1

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Background

Methods

Results

Conclusion

Log in om toegang te krijgen

Andere artikelen Uitgave 3/2023

Return to Baseline After an Interpretation Training as a Dynamic Predictor for Treatment Response in Social Anxiety Disorder

Safety Behaviors Predict Long-Term Treatment Outcome Following Internet-Based Treatment of Adults with Social Anxiety Disorder

Beyond Positive Affect: Discrete Positive Emotions Differentiate Major Depression from Social Anxiety Disorder

Perfectionism as Possible Predictor for Treatment Success in Mindfulness-Based Cognitive Therapy and Metacognitive Training as Third-Wave Treatments for Obsessive-Compulsive Disorder

What Cognitions Best Predict Disturbed Anger in Adults? A Revision of the Anger Cognitions Scale

The Moderating Role of Intolerance of Uncertainty in the Relationship Between Health Anxiety and Pandemic-Related Stress